Why Walgreens Suspended Its Dividend
Walgreens stock spiraled Friday after the pharmacy chain suspended its dividend amid continued turnaround plans. Here's what you need to know.


Walgreens Boots Alliance (WBA) stock was one of the worst-performing S&P 500 stocks on Friday, January 31, after the drugstore chain announced it is suspending its quarterly dividend.
"This change in capital allocation is aimed at strengthening WBA's balance sheet by reducing debt over time and improving free cash flow, as the company works toward achieving a retail pharmacy-led turnaround underpinned by a sustainable economic model," Walgreens said in a statement.
The company added that its "cash needs over the next several years," which includes litigation and debt refinancing, "were important considerations as part of the decision to suspend the dividend."

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The move comes just three weeks after Walgreens beat top- and bottom-line expectations for its fiscal 2025 first quarter and maintained its full-year profit forecast.
However, based on Walgreens' forecast for full-year earnings of $1.40 to $1.80 per share, its 25 cents per share quarterly dividend would have resulted in a full-year payout ratio [how much it costs a company to pay its dividend as a percentage of earnings] of 55.6% to 71.4%. And this would not be a prudent use of capital in a turnaround situation.
Walgreens did not provide any indication as to if or when the dividend would be reinstated.
Is Walgreens stock a buy, sell or hold?
Walgreens Boots Alliance's struggles have extended to the price charts, as well, with shares of the former Dow Jones stock down roughly 60% in the past 12 months. Unsurprisingly, Wall Street is on the sidelines when it comes to the consumer discretionary stock.
According to S&P Global Market Intelligence, the average analyst target price for WBA stock is $12.35. While this represents implied upside of more than 20% to current levels, it's more likely a case of analysts failing to keep up with the falling share price vs expectations for a major rally. Meanwhile, the consensus recommendation is Hold.
Financial services firm UBS Global Research is one of those with a Neutral rating (equivalent to a Hold) on WBA stock, along with an $11 price target.
"A [dividend] cut was widely anticipated by investors given depressed cash flow, elevated leverage, and limited balance sheet flexibility barring a sale of assets," says UBS Global Research analyst Kevin Caliendo. The company will save roughly $86 million by suspending its dividend, "which will likely be used to manage near-term working capital needs, pay down near-term debt, and potentially fund improvements into the core business," he notes.
Caliendo adds that the dividend cut may also indicate that a potential buyout or large asset sale will not occur in the near term.
Related Content
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
Joey Solitro is a freelance financial journalist at Kiplinger with more than a decade of experience. A longtime equity analyst, Joey has covered a range of industries for media outlets including The Motley Fool, Seeking Alpha, Market Realist, and TipRanks. Joey holds a bachelor's degree in business administration.
-
Stagflation: What It Is and Why Retirees Should Care
Stagflation — the economic bogeyman of the 1970's — may return to the US. Here's what it could mean to your retirement.
By Donna Fuscaldo Published
-
Why Losing Your Job Could Be the Best Opportunity to Plan Your Future
Amid this uncertainty lies an opportunity for strategic reassessment and personal growth.
By Mario Hernandez Published
-
Can a New Manager Cure Vanguard Health Care Fund?
Vanguard Health Care Fund has assets of $40.5 billion but has been ailing in recent years. With a new manager in charge, what's the prognosis?
By Nellie S. Huang Published
-
What You Don't Know About Annuities Can Hurt You
Lack of awareness leads many to overlook these potent financial tools, and with the possibility of running out of money in retirement, that could really hurt.
By Ken Nuss Published
-
Three Keys to Logical Investing When Markets Are Volatile
Focusing on these market fundamentals can help investors stay grounded rather than being swayed by emotion or market hysteria.
By Dennis D. Coughlin, CFP, AIF Published
-
Yes, the Markets Are Spooked, But You Don't Have to Be
It's human nature for investors to freak out in a downturn. But with a little discipline, you can overcome the urge to sell and stay focused on long-term goals.
By Jimmy Lee, IAR Published
-
Remembering Bogle: A New Standard for Municipal Investing
Improvements in technology, data, systematic trading and risk analytics have led to more successful municipal indexing.
By Paul Malloy Published
-
Stock Market Today: Stocks Are Mixed Before Liberation Day
Markets are getting into the freewheeling rhythm of a second Trump administration.
By David Dittman Published
-
How to Invest in Sports
If it's springtime, Forbes is out with its annual list of baseball franchise values. The billions involved might make you wonder how to invest in sports.
By David Dittman Published
-
Winning Strategies for Financial Advisers as Clients' Lives Evolve
How can the wealth management industry help make life transitions easier for the adviser and the client?
By David Conti, CPRC Published